Paras Healthcare IPO Day 3: Latest GMP, Subscription Status, and Essential Insights You Need to Know!

The IPO of Paras Healthcare has entered its final day of bidding on October 23, amid a measured investor response. As of Day 2, the overall subscription level stood at 34% of the issue size, which consists of 1.20 crore shares. The price band for the IPO has been set at Rs 660-693 per share, requiring a minimum investment of Rs 14,553 for retail investors applying for a single lot. Notably, the retail individual investor (RII) segment managed to attract a subscription of 1.31 times, reflecting a more positive sentiment within this category compared to the overall demand.

The grey market sentiment surrounding the IPO indicates a premium of around 2%, equating to an estimated listing price of approximately Rs 706 per share. This modest premium suggests a cautious optimism among investors, though it reflects a limited upside from the issue price. The investor rankings within the qualified institutional buyer (QIB) segment were notably tepid, only receiving bids for about 6% of the 65.90 lakh shares available, further emphasizing the overall subdued demand for the offering. The final allotment is expected to be finalized on October 26, with shares tentatively scheduled to debut on both the BSE and NSE on October 28, 2026.

For Indian investors, particularly retail participants, the IPO could serve as a strategic opportunity for those looking to invest in a healthcare company with significant growth prospects. Paras Healthcare reported a substantial increase in total income and achieved profitability, which can be reassuring factors for potential investors. However, the subdued grey market premium and the mixed subscription levels should prompt caution and a careful evaluation before making investment decisions in the context of the broader market landscape.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)